Your browser doesn't support javascript.
loading
Analytical performance specifications based on biological variation data - considerations, strengths and limitations.
Sandberg, Sverre; Coskun, Abdurrahman; Carobene, Anna; Fernandez-Calle, Pilar; Diaz-Garzon, Jorge; Bartlett, William A; Jonker, Niels; Galior, Kornelia; Gonzales-Lao, Elisabet; Moreno-Parro, Isabel; Sufrate-Vergara, Berta; Webster, Craig; Aarsand, Aasne K.
Afiliação
  • Sandberg S; Norwegian Organization for Quality Improvement of Laboratory Examinations (Noklus), 72982 Haraldsplass Deaconess Hospital , Bergen, Norway.
  • Coskun A; Department of Medical Biochemistry and Pharmacology, The Norwegian Porphyria Centre, Haukeland University Hospital, Bergen, Norway.
  • Carobene A; Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway.
  • Fernandez-Calle P; Department of Medical Biochemistry Atasehir, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Türkiye.
  • Diaz-Garzon J; Laboratory Medicine, 9372 IRCCS San Raffaele Scientific Institute , Milan, Italy.
  • Bartlett WA; Laboratory Medicine Department, 16268 La Paz University Hospital , Madrid, Spain.
  • Jonker N; Laboratory Medicine Department, 16268 La Paz University Hospital , Madrid, Spain.
  • Galior K; Biomedical Engineering, School of Engineering and Science, 85326 University of Dundee , Dundee, Scotland.
  • Gonzales-Lao E; Certe, Wilhelmina Ziekenhuis Assen, Assen, The Netherlands.
  • Moreno-Parro I; Department of Pathology and Laboratory Medicine, 1371 Emory University , Atlanta, GA, USA.
  • Sufrate-Vergara B; Quality and Patient Safety Department, 16377 Consorci Sanitari de Terrassa University Hospital , Barcelona, Spain.
  • Webster C; Laboratory Medicine Department, 16268 La Paz University Hospital , Madrid, Spain.
  • Aarsand AK; Laboratory Medicine Department, 16268 La Paz University Hospital , Madrid, Spain.
Clin Chem Lab Med ; 62(8): 1483-1489, 2024 Jul 26.
Article em En | MEDLINE | ID: mdl-38501489
ABSTRACT
Analytical performance specifications (APS) are typically established through one of three models (i) outcome studies, (ii) biological variation (BV), or (iii) state-of-the-art. Presently, The APS can, for most measurands that have a stable concentration, be based on BV. BV based APS, defined for imprecision, bias, total allowable error and allowable measurement uncertainty, are applied to many different processes in the laboratory. When calculating APS, it is important to consider the different APS formulae, for what setting they are to be applied and if they are suitable for the intended purpose. In this opinion paper, we elucidate the background, limitations, strengths, and potential intended applications of the different BV based APS formulas. When using BV data to set APS, it is important to consider that all formulae are contingent on accurate and relevant BV estimates. During the last decade, efficient procedures have been established to obtain reliable BV estimates that are presented in the EFLM biological variation database. The database publishes detailed BV data for numerous measurands, global BV estimates derived from meta-analysis of quality-assured studies of similar study design and automatic calculation of BV based APS.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Variação Biológica da População Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Variação Biológica da População Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article